|
|
|
| Webinar: Rewriting the Code: Advances and Challenges in Pediatric Gene Therapy | Pediatric gene therapy is rapidly transforming treatment for rare genetic diseases. Join Dr. Rachel Abu Taleb as she explores AAV, lentiviral, and CRISPR platforms, reviews lessons from approved therapies, and examines the scientific, regulatory, and access challenges shaping future innovation. Learn how these advances are redefining care and improving outcomes for children with rare diseases. Click here to learn more. |
|
|
|
|
A conversation between CuraCell CEO Torbjörn Ström and Clinical Leader executive editor Abby Proch | CuraCell Head of Clinical Operations Torbjörn Ström discusses, in the context of CC-38 and CytoPLY-derived tumor-infiltrating lymphocytes (TILs), the utility of named-patient experience, dosing and preconditioning, and T-cell therapy capabilities in cold solid tumors. | |
|
|
| Galvanizing Large And Small For Clinical Success | Article | RoosterBio | See how two academic investigators accelerated corneal regeneration and lung fibrosis therapies from preclinical research to clinical trials by leveraging scalable GMP solutions and regulatory-ready materials. |
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|
